ArticleWorld journal of surgical oncology2026
Adjuvant chemotherapy and lymph node examination interact to shape survival in older adults (≥ 75 years) with resected gastric cancer: a SEER-based propensity score-matched and competing-risk analysis.
Article in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence for adjuvant chemotherapy (ACT) in very old gastric cancer patients is limited, and inadequate lymph node (LN) examination may affect staging and treatment selection. We assessed whether LN examination modifies the association between ACT and survival in older adults.
methodsFrom SEER (2010-2015), we identified patients aged ≥ 75 years who underwent resection for gastric cancer. LN examination was grouped as < 15 vs. ≥ 15. Overall survival (OS) was evaluated using Cox models. Cancer-specific death was analyzed with cumulative incidence functions and Fine-Gray regression. To mitigate treatment-selection bias, we used multivariable adjustment, propensity score matching (PSM), and stabilized inverse probability of treatment weighting (IPTW). Effect modification was tested using ACT×LN interaction terms; LN count was also explored continuously with restricted cubic splines.
resultsThe cohort included 825 patients; 386 were retained after PSM. ACT-outcome estimates differed by LN examination. ACT was more favorably associated with outcomes among patients with ≥ 15 nodes examined, while estimates were weaker and less consistent when < 15 nodes were assessed. Interaction signals appeared in crude and some adjusted models but were attenuated, while remaining directionally consistent, in IPTW sensitivity analyses, suggesting susceptibility to residual confounding and modeling assumptions. Competing-risk analyses highlighted substantial non-cancer mortality. In a low-risk-exclusion cohort (N = 306), ACT remained favorably associated with outcomes, with less evidence of interaction.
conclusionsAmong resected gastric cancer patients aged ≥ 75 years, the observed association between ACT and survival differed by LN examination extent, with more favorable estimates generally seen when ≥ 15 nodes are examined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.